<ѻýҕl>Wegovy Helps HFpEF Patients With Diabetes Mellitusѻýҕl> Weight and symptoms improved in STEP-HFpEF DM trial Apr 07, 2024
<ѻýҕl>Proof of Benefit in Acute MI Again Evades an SGLT2 Inhibitorѻýҕl> Yet empagliflozin gets a boost from a lower risk of total HF events in EMPACT-MI Apr 07, 2024
<ѻýҕl>Cardiology's Bid to Defect From ABIM Plows Aheadѻýҕl> Application to form a new board is in, and it could be operational as soon as 2025 Apr 07, 2024
<ѻýҕl>Interatrial Shunt's Prospects in Heart Failure Shrink After RELIEVE-HFѻýҕl> Ventura device showed promise in narrower pool of HF patients with reduced EF Apr 07, 2024
<ѻýҕl>ACC Meeting to Make Noise on Beta-Blockers, SGLT2i, Chelation Therapy for Acute MIѻýҕl> Plus an update on the new cardiovascular board at Atlanta meeting Apr 04, 2024
<ѻýҕl>More Sophisticated Imaging Doesn't Necessarily Mean Better Outcomes in Ischemic HFѻýҕl> But cardiac MRI, PET may still have value in some patients, per AIMI-HF trial Mar 09, 2023
<ѻýҕl>Adaptive Pacemaker Fails in HFpEFѻýҕl> Improvement in oxygen consumption response to physical exertion not observed in a small trial Mar 09, 2023
<ѻýҕl>Pulsed Field Afib Ablation Hits Endpoints in Pivotal Trialѻýҕl> Technology appears durable in most patients Mar 08, 2023
<ѻýҕl>Virtual Care Team Optimized Heart Failure Medications During Hospitalizationѻýҕl> Trial shows modest effect with daily recommendations to the treating team Mar 07, 2023
<ѻýҕl>Statin Users Show LDL Doesn't Come Close to Telling Whole Story of ASCVDѻýҕl> Residual inflammation is important factor of cardiovascular risk Mar 07, 2023
<ѻýҕl>Elite Athletes With Genetic Heart Disease Can Still Play Ballѻýҕl> With a comprehensive return-to-play protocol, most athletes played again, researchers say Mar 07, 2023
<ѻýҕl>Full-Dose Anticoagulation Again Favored for COVID Admissionsѻýҕl> Despite failures, FREEDOM trial supports mortality advantage in general ward use Mar 07, 2023
<ѻýҕl>Sotatercept, Fixed-Dose Combo Therapy on the Right Path for PAHѻýҕl> More therapeutic options suggested by STELLAR, A DUE trials Mar 06, 2023
<ѻýҕl>Thrombectomy Linked to Better High-Risk Pulmonary Embolism Outcomesѻýҕl> Observational study suggests fewer deaths than with other approaches Mar 06, 2023
<ѻýҕl>TAVR Holds Strong 3 Years Into Evolut Low Risk Trialѻýҕl> No major widening nor narrowing of event curves yet Mar 06, 2023
<ѻýҕl>No Copay Is No Help for CVD Outcomesѻýҕl> Randomized trial showed a small bump in adherence, but didn't move the dial on outcomes Mar 06, 2023
<ѻýҕl>Minimally Invasive Mitral Valve Surgery Earns Confidence in Expert Handsѻýҕl> Decision for mini thoracotomy may rest on patient preference, expert operator availability Mar 06, 2023
<ѻýҕl>Immediate Complete Revascularization Non-Inferior to Staged Procedureѻýҕl> Patients with ACS and multivessel disease saw multiple outcome benefits in BIOVASC trial Mar 05, 2023
<ѻýҕl>Hunt for Hibernating Myocardium Doesn't Help PCI for Ischemic Cardiomyopathyѻýҕl> REVIVED-BCIS2 challenges long-held beliefs about myocardial viability Mar 05, 2023
<ѻýҕl>Novel Antihypertensive Stumbles Over Early-Phase Hurdleѻýҕl> Hopes remain high for baxdrostat despite trial's adherence problems Mar 05, 2023
<ѻýҕl>TEER Improves Quality of Life With Severe Tricuspid Regurgitationѻýҕl> Pivotal trial is first to evaluate "impact of TR reduction on long-term effects on survival" Mar 04, 2023
<ѻýҕl>Bempedoic Acid Proves Clinical Benefits for the Statin-Intolerantѻýҕl> Yet the good clinical data are complicated by real-world cost and access problems Mar 04, 2023
<ѻýҕl>Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclinesѻýҕl> STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients." Mar 04, 2023
<ѻýҕl>Gender Affirmation Hormones Come With Cardiovascular Tradeoffsѻýҕl> National hospital data add to the literature on HRT's risk-benefit profile Feb 27, 2023
<ѻýҕl>Anticoagulation Goes Head-to-Head With DAPT After Valve Surgeryѻýҕl> Edoxaban not significantly better for thrombosis protection in "underpowered" ADAPT-TAVR trial Apr 06, 2022
<ѻýҕl>Two PCI Guidance Strategies on Par for Intermediate Coronary Stenosisѻýҕl> FLAVOUR trial weighs in on FFR versus IVUS Apr 05, 2022
<ѻýҕl>Which Drug-Coated Balloon Proved Superior in Peripheral Artery Disease?ѻýҕl> Second-generation device goes head-to-head with popular first-gen device Apr 05, 2022
<ѻýҕl>Cardiac Monitoring Finds Arrhythmias, but Treatment Did Not Improve Outcomesѻýҕl> No differences in mortality, hospitalization between monitored patients and control patients Apr 05, 2022
<ѻýҕl>TAVR Valve Outlasts Surgical Bioprostheses at 5 Yearsѻýҕl> No longer assume that TAVR bioprostheses are inherently less durable Apr 05, 2022
<ѻýҕl>Study Provides 'Elusive' Link Between Kids' Health and Adult Heart Eventsѻýҕl> CV risk factors in childhood tied to midlife CV events and CVD Apr 05, 2022
<ѻýҕl>Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HFѻýҕl> Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
<ѻýҕl>Transcatheter Tricuspid Repair Shows Early Promiseѻýҕl> PASCAL device safe and linked to symptom improvement in severe tricuspid regurgitation Apr 04, 2022
<ѻýҕl>Extra Warming Efforts in Surgery Turn Out to Be Hot Airѻýҕl> PROTECT trial finds targeting body temperatures a few degrees higher is unnecessary Apr 04, 2022
<ѻýҕl>Flu Vaccine Didn't Stop Vascular Events in Heart Failure Patientsѻýҕl> But study in lower income countries sees hint of benefit during peak disease season Apr 04, 2022
<ѻýҕl>Shoppers Adhered to Heart-Healthy Diet in Novel Programѻýҕl> Researchers teamed with supermarket chain to improve DASH scores Apr 04, 2022
<ѻýҕl>Don't Wait, Ablate to Prevent VT Episodes After an ICD Shock?ѻýҕl> Early catheter ablation reduced deaths and ICD shocks in PARTITA trial Apr 03, 2022
<ѻýҕl>EHR Pop-Ups Spur Better GDMT Implementation in Heart Failureѻýҕl> Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
<ѻýҕl>Higher-Dose ANGPTL3 Inhibitor Cuts Lipids but With Questionable Safetyѻýҕl> Significant safety signals in dose-ranging trial may end drug's future in CV prevention Apr 03, 2022
<ѻýҕl>Add-On Mavacamten Cuts Need for Septal Reduction in Obstructive HCMѻýҕl> VALOR-HCM trial shows novel cardiac myosin inhibitor beneficial as targeted treatment Apr 02, 2022
<ѻýҕl>Tide Turns on Withholding Blood Pressure Meds for Pregnant Womenѻýҕl> Antihypertensive treatment was safe for mothers and children in the CHAP trial Apr 02, 2022